FDA Approves At-Home Self-Collection Device for Cervical Cancer Screening

Teal Health's FDA-approved Teal Wand™ offers an at-home cervical cancer screening option for women aged 25 to 65 years at average risk for cervical cancer. This device, supported by data from the SELF-CERV study, also comes with virtual access to medical providers, uses the highly accurate cobas® HPV test, and has the same performance as clinician-collected samples. The comprehensive telehealth service and flexible payment options associated with the device aim to improve screening adherence and outcomes, according to Teal Health.

Source: Teal Health